Research progress of azvudine in the treatment of novel coro-navirus infection
Dongmei Zhang1
Suling Chen2
Chao Liu2
1.The First Clinical College of Changzhi Medical College,Teaching and Research Office of Infectious Diseases of First Clinical College Attached to Changzhi Medical College2.Department of Infectious Disease,Heping Hospital Affiliated to Changzhi Medical College,Changzhi,046000,ShanXi Province,China
摘要：The novel coronavirus known as severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)is constantly mutating,with Omicron and its branches being the main circulating strains in the ongoing global pandemic.Azvu-dine,a small-molecule drug independently developed in China to treat HIV,is the first nucleoside-based,dual-tar-geted antiviral agent.Clinical studies have shown that azvudine has relatively good safety and efficacy profiles.This article provides an overview of the background,mechanism of action,efficacy,safety,and drug interactions of azvudine for the treatment of SARS-CoV-2 infection.
机标关键词：researchnovelazvudinecoro-navirusinfectionprogresstreatment
论文发表日期：2024-03-30
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：9( 32-40 )
英文信息